hexylcaine: RN given refers to parent cpd; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 10770 |
| CHEMBL ID | 1197 |
| CHEBI ID | 34791 |
| SCHEMBL ID | 34238 |
| MeSH ID | M0046190 |
| Synonym |
|---|
| BRD-A97730597-003-03-2 |
| hexylcaine |
| 1-(cyclohexylamino)-2-propanol benzoate (ester) |
| PRESTWICK2_000788 |
| 532-77-4 |
| BPBIO1_000986 |
| hexylcainum [inn-latin] |
| 2-propanol, 1-(cyclohexylamino)-, benzoate (ester) |
| (2-cyclohexylamino-1-methylethyl) benzoate |
| hexilcaina [inn-spanish] |
| hexylcaine [inn] |
| NCGC00179382-01 |
| PRESTWICK3_000788 |
| BSPBIO_000896 |
| AB00514688 |
| DB00473 |
| PRESTWICK1_000788 |
| SPBIO_002835 |
| PRESTWICK0_000788 |
| 1-(cyclohexylamino)propan-2-yl benzoate |
| osmocaine |
| chebi:34791 , |
| CHEMBL1197 |
| benzoic acid 2-cyclohexylamino-1-methyl-ethyl ester |
| unii-511iu0826z |
| hexilcaina |
| hexylcainum |
| 511iu0826z , |
| hexylcaine [who-dd] |
| gtpl7196 |
| SCHEMBL34238 |
| DTXSID1047863 |
| 2-(cyclohexylamino)-1-methylethyl benzoate # |
| hexylcainc |
| Q5749095 |
| bdbm50225698 |
| cyclain; osmocaine |
| EN300-25300387 |
| Class | Description |
|---|---|
| benzoate ester | Esters of benzoic acid or substituted benzoic acids. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID450269 | Displacement of [3H]-BTX-B from neuronal voltage-gated sodium channel in rat cerebral cortex synaptoneurosomes | 2009 | Bioorganic & medicinal chemistry, Oct-01, Volume: 17, Issue:19 | Ligand-based design and synthesis of novel sodium channel blockers from a combined phenytoin-lidocaine pharmacophore. |
| AID205267 | Inhibition of binding of Batrachotoxinin [3H]BTX-B to high affinity sites on voltage dependent sodium channels in a vesicular preparation from guinea pig cerebral cortex | 1985 | Journal of medicinal chemistry, Mar, Volume: 28, Issue:3 | [3H]Batrachotoxinin A 20 alpha-benzoate binding to voltage-sensitive sodium channels: a rapid and quantitative assay for local anesthetic activity in a variety of drugs. |
| AID450273 | Lipophilicity, log P of the compound | 2009 | Bioorganic & medicinal chemistry, Oct-01, Volume: 17, Issue:19 | Ligand-based design and synthesis of novel sodium channel blockers from a combined phenytoin-lidocaine pharmacophore. |
| AID205268 | Inhibition of binding of Batrachotoxinin [3H]BTX-B to high affinity sites on voltage dependent sodium channels in a vesicular preparation from guinea pig cerebral cortex at 10 uM | 1985 | Journal of medicinal chemistry, Mar, Volume: 28, Issue:3 | [3H]Batrachotoxinin A 20 alpha-benzoate binding to voltage-sensitive sodium channels: a rapid and quantitative assay for local anesthetic activity in a variety of drugs. |
| AID1159607 | Screen for inhibitors of RMI FANCM (MM2) intereaction | 2016 | Journal of biomolecular screening, Jul, Volume: 21, Issue:6 | A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 28 (93.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (3.33) | 29.6817 |
| 2010's | 1 (3.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 32 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Substance | Description | Relationhip Strength | Studies | Trials | Classes | Roles |
|---|---|---|---|---|---|---|
| quinacrine | [no description available] | medium | 1 | 0 | acridines; aromatic ether; organochlorine compound; tertiary amino compound | antimalarial; EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor |
| gallopamil | [no description available] | medium | 1 | 0 | benzenes; organic amino compound | |
| 4-aminopyridine | [no description available] | medium | 1 | 0 | aminopyridine; aromatic amine | avicide; orphan drug; potassium channel blocker |
| phenytoin | [no description available] | medium | 2 | 0 | imidazolidine-2,4-dione | anticonvulsant; drug allergen; sodium channel blocker; teratogenic agent |
| 8-(4-sulfophenyl)theophylline | [no description available] | medium | 1 | 0 | ||
| 8-phenyltheophylline | [no description available] | medium | 1 | 0 | ||
| theophylline | [no description available] | medium | 1 | 0 | dimethylxanthine | adenosine receptor antagonist; anti-asthmatic drug; anti-inflammatory agent; bronchodilator agent; drug metabolite; EC 3.1.4.* (phosphoric diester hydrolase) inhibitor; fungal metabolite; human blood serum metabolite; immunomodulator; muscle relaxant; vasodilator agent |
| amitriptyline | [no description available] | medium | 1 | 0 | carbotricyclic compound; tertiary amine | adrenergic uptake inhibitor; antidepressant; environmental contaminant; tropomyosin-related kinase B receptor agonist; xenobiotic |
| anisindione | [no description available] | medium | 1 | 0 | aromatic ketone; beta-diketone | anticoagulant; vitamin K antagonist |
| baclofen | [no description available] | medium | 1 | 0 | amino acid zwitterion; gamma-amino acid; monocarboxylic acid; monochlorobenzenes; primary amino compound | central nervous system depressant; GABA agonist; muscle relaxant |
| benzocaine | [no description available] | medium | 2 | 0 | benzoate ester; substituted aniline | allergen; antipruritic drug; sensitiser; topical anaesthetic |
| bepridil | [no description available] | medium | 1 | 0 | pyrrolidines; tertiary amine | anti-arrhythmia drug; antihypertensive agent; calcium channel blocker; vasodilator agent |
| biperiden | [no description available] | medium | 1 | 0 | piperidines; tertiary alcohol; tertiary amino compound | antidote to sarin poisoning; antidyskinesia agent; antiparkinson drug; muscarinic antagonist; parasympatholytic |
| bupivacaine | [no description available] | medium | 3 | 0 | aromatic amide; piperidinecarboxamide; tertiary amino compound | |
| buspirone | [no description available] | medium | 1 | 0 | azaspiro compound; N-alkylpiperazine; N-arylpiperazine; organic heteropolycyclic compound; piperidones; pyrimidines | anxiolytic drug; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; sedative; serotonergic agonist |
| butacaine | [no description available] | medium | 1 | 0 | benzoate ester | |
| butamben | [no description available] | medium | 1 | 0 | amino acid ester; benzoate ester; primary amino compound; substituted aniline | local anaesthetic |
| caffeine | [no description available] | medium | 1 | 0 | purine alkaloid; trimethylxanthine | adenosine A2A receptor antagonist; adenosine receptor antagonist; adjuvant; central nervous system stimulant; diuretic; EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor; EC 3.1.4.* (phosphoric diester hydrolase) inhibitor; environmental contaminant; food additive; fungal metabolite; geroprotector; human blood serum metabolite; mouse metabolite; mutagen; plant metabolite; psychotropic drug; ryanodine receptor agonist; xenobiotic |
| verapamil | [no description available] | medium | 1 | 0 | aromatic ether; nitrile; polyether; tertiary amino compound | |
| carbamazepine | [no description available] | medium | 1 | 0 | dibenzoazepine; ureas | analgesic; anticonvulsant; antimanic drug; drug allergen; EC 3.5.1.98 (histone deacetylase) inhibitor; environmental contaminant; glutamate transporter activator; mitogen; non-narcotic analgesic; sodium channel blocker; xenobiotic |
| chlordiazepoxide | [no description available] | medium | 1 | 0 | benzodiazepine | |
| chlorpheniramine | [no description available] | medium | 1 | 0 | monochlorobenzenes; pyridines; tertiary amino compound | anti-allergic agent; antidepressant; antipruritic drug; H1-receptor antagonist; histamine antagonist; serotonin uptake inhibitor |
| chlorpromazine | [no description available] | medium | 1 | 0 | organochlorine compound; phenothiazines; tertiary amine | anticoronaviral agent; antiemetic; dopaminergic antagonist; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; phenothiazine antipsychotic drug |
| cimetidine | [no description available] | medium | 1 | 0 | aliphatic sulfide; guanidines; imidazoles; nitrile | adjuvant; analgesic; anti-ulcer drug; H2-receptor antagonist; P450 inhibitor |
| clomipramine | [no description available] | medium | 1 | 0 | dibenzoazepine | anticoronaviral agent; antidepressant; EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor; serotonergic antagonist; serotonergic drug; serotonin uptake inhibitor |
| cyproheptadine | [no description available] | medium | 1 | 0 | piperidines; tertiary amine | anti-allergic agent; antipruritic drug; gastrointestinal drug; H1-receptor antagonist; serotonergic antagonist |
| desipramine | [no description available] | medium | 1 | 0 | dibenzoazepine; secondary amino compound | adrenergic uptake inhibitor; alpha-adrenergic antagonist; antidepressant; cholinergic antagonist; drug allergen; EC 3.1.4.12 (sphingomyelin phosphodiesterase) inhibitor; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; H1-receptor antagonist; serotonin uptake inhibitor |
| diazepam | [no description available] | medium | 1 | 0 | 1,4-benzodiazepinone; organochlorine compound | anticonvulsant; anxiolytic drug; environmental contaminant; sedative; xenobiotic |
| diazoxide | [no description available] | medium | 1 | 0 | benzothiadiazine; organochlorine compound; sulfone | antihypertensive agent; beta-adrenergic agonist; bronchodilator agent; cardiotonic drug; diuretic; K-ATP channel agonist; sodium channel blocker; sympathomimetic agent; vasodilator agent |
| dibucaine | [no description available] | medium | 2 | 0 | aromatic ether; monocarboxylic acid amide; tertiary amino compound | topical anaesthetic |
| dicyclomine | [no description available] | medium | 1 | 0 | carboxylic ester; tertiary amine | antispasmodic drug; muscarinic antagonist; parasympatholytic |
| diphenidol | [no description available] | medium | 1 | 0 | benzenes; piperidines; tertiary alcohol | antiemetic |
| dilazep | [no description available] | medium | 1 | 0 | benzoate ester; diazepane; diester; methoxybenzenes | cardioprotective agent; platelet aggregation inhibitor; vasodilator agent |
| diphenhydramine | [no description available] | medium | 1 | 0 | ether; tertiary amino compound | anti-allergic agent; antidyskinesia agent; antiemetic; antiparkinson drug; antipruritic drug; antitussive; H1-receptor antagonist; local anaesthetic; muscarinic antagonist; oneirogen; sedative |
| dipyridamole | [no description available] | medium | 1 | 0 | piperidines; pyrimidopyrimidine; tertiary amino compound; tetrol | adenosine phosphodiesterase inhibitor; EC 3.5.4.4 (adenosine deaminase) inhibitor; platelet aggregation inhibitor; vasodilator agent |
| doxepin | [no description available] | medium | 1 | 0 | dibenzooxepine; tertiary amino compound | antidepressant |
| droperidol | [no description available] | medium | 1 | 0 | aromatic ketone; benzimidazoles; organofluorine compound | anaesthesia adjuvant; antiemetic; dopaminergic antagonist; first generation antipsychotic |
| etazolate | [no description available] | medium | 1 | 0 | ethyl ester; hydrazone; pyrazolopyridine | alpha-secretase activator; antidepressant; antipsychotic agent; anxiolytic drug; GABA agent; neuroprotective agent; phosphodiesterase IV inhibitor |
| felodipine | [no description available] | medium | 1 | 0 | dichlorobenzene; dihydropyridine; ethyl ester; methyl ester | anti-arrhythmia drug; antihypertensive agent; calcium channel blocker; vasodilator agent |
| flufenamic acid | [no description available] | medium | 1 | 0 | aromatic amino acid; organofluorine compound | antipyretic; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; non-narcotic analgesic; non-steroidal anti-inflammatory drug |
| fluphenazine | [no description available] | medium | 1 | 0 | N-alkylpiperazine; organofluorine compound; phenothiazines | anticoronaviral agent; dopaminergic antagonist; phenothiazine antipsychotic drug |
| flumazenil | [no description available] | medium | 1 | 0 | ethyl ester; imidazobenzodiazepine; organofluorine compound | antidote to benzodiazepine poisoning; GABA antagonist |
| haloperidol | [no description available] | medium | 1 | 0 | aromatic ketone; hydroxypiperidine; monochlorobenzenes; organofluorine compound; tertiary alcohol | antidyskinesia agent; antiemetic; dopaminergic antagonist; first generation antipsychotic; serotonergic antagonist |
| hydroxyzine | [no description available] | medium | 1 | 0 | hydroxyether; monochlorobenzenes; N-alkylpiperazine | anticoronaviral agent; antipruritic drug; anxiolytic drug; dermatologic drug; H1-receptor antagonist |
| lidocaine | [no description available] | medium | 5 | 0 | benzenes; monocarboxylic acid amide; tertiary amino compound | anti-arrhythmia drug; drug allergen; environmental contaminant; local anaesthetic; xenobiotic |
| ici 118551 | [no description available] | medium | 1 | 0 | indanes | |
| imipramine | [no description available] | medium | 1 | 0 | dibenzoazepine | adrenergic uptake inhibitor; antidepressant; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor |
| indomethacin | [no description available] | medium | 1 | 0 | aromatic ether; indole-3-acetic acids; monochlorobenzenes; N-acylindole | analgesic; drug metabolite; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; environmental contaminant; gout suppressant; non-steroidal anti-inflammatory drug; xenobiotic metabolite; xenobiotic |
| 1-methyl-3-isobutylxanthine | [no description available] | medium | 1 | 0 | 3-isobutyl-1-methylxanthine | |
| loperamide | [no description available] | medium | 1 | 0 | monocarboxylic acid amide; monochlorobenzenes; piperidines; tertiary alcohol | anticoronaviral agent; antidiarrhoeal drug; mu-opioid receptor agonist |
| mepivacaine | [no description available] | medium | 1 | 0 | piperidinecarboxamide | drug allergen; local anaesthetic |
| benzoic acid [2-methyl-2-(propylamino)propyl] ester | [no description available] | medium | 1 | 0 | benzoate ester | |
| metoprolol | [no description available] | medium | 1 | 0 | aromatic ether; propanolamine; secondary alcohol; secondary amino compound | antihypertensive agent; beta-adrenergic antagonist; environmental contaminant; geroprotector; xenobiotic |
| mianserin | [no description available] | medium | 1 | 0 | dibenzoazepine | adrenergic uptake inhibitor; alpha-adrenergic antagonist; antidepressant; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; geroprotector; H1-receptor antagonist; histamine agonist; sedative; serotonergic antagonist |
| nifedipine | [no description available] | medium | 1 | 0 | C-nitro compound; dihydropyridine; methyl ester | calcium channel blocker; human metabolite; tocolytic agent; vasodilator agent |
| nisoldipine | [no description available] | medium | 1 | 0 | C-nitro compound; dicarboxylic acids and O-substituted derivatives; diester; dihydropyridine; methyl ester | |
| nitrendipine | [no description available] | medium | 1 | 0 | C-nitro compound; dicarboxylic acids and O-substituted derivatives; diester; dihydropyridine; ethyl ester; methyl ester | antihypertensive agent; calcium channel blocker; geroprotector; vasodilator agent |
| nortriptyline | [no description available] | medium | 1 | 0 | organic tricyclic compound; secondary amine | adrenergic uptake inhibitor; analgesic; antidepressant; antineoplastic agent; apoptosis inducer; drug metabolite |
| oxethazaine | [no description available] | medium | 1 | 0 | amino acid amide | |
| benoxinate | [no description available] | medium | 1 | 0 | amino acid ester; benzoate ester; substituted aniline; tertiary amino compound | drug allergen; local anaesthetic; topical anaesthetic |
| papaverine | [no description available] | medium | 1 | 0 | benzylisoquinoline alkaloid; dimethoxybenzene; isoquinolines | antispasmodic drug; vasodilator agent |
| pentobarbital | [no description available] | medium | 1 | 0 | barbiturates | GABAA receptor agonist |
| pheniramine | [no description available] | medium | 1 | 0 | pyridines; tertiary amino compound | |
| phenobarbital | [no description available] | medium | 1 | 0 | barbiturates | anticonvulsant; drug allergen; excitatory amino acid antagonist; sedative |
| phenoxybenzamine | [no description available] | medium | 1 | 0 | aromatic amine | |
| practolol | [no description available] | medium | 1 | 0 | acetamides; ethanolamines; propanolamine; secondary alcohol; secondary amino compound | anti-arrhythmia drug; beta-adrenergic antagonist |
| pramoxine | [no description available] | medium | 1 | 0 | aromatic ether; morpholines | local anaesthetic |
| prazosin | [no description available] | medium | 1 | 0 | aromatic ether; furans; monocarboxylic acid amide; piperazines; quinazolines | alpha-adrenergic antagonist; antihypertensive agent; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor |
| prilocaine | [no description available] | medium | 2 | 0 | amino acid amide; monocarboxylic acid amide | anticonvulsant; local anaesthetic |
| proadifen | [no description available] | medium | 1 | 0 | diarylmethane | |
| procainamide | [no description available] | medium | 1 | 0 | benzamides | anti-arrhythmia drug; platelet aggregation inhibitor; sodium channel blocker |
| procaine | [no description available] | medium | 6 | 0 | benzoate ester; substituted aniline; tertiary amino compound | central nervous system depressant; drug allergen; local anaesthetic; peripheral nervous system drug |
| promazine | [no description available] | medium | 1 | 0 | phenothiazines; tertiary amine | antiemetic; dopaminergic antagonist; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; H1-receptor antagonist; muscarinic antagonist; phenothiazine antipsychotic drug; serotonergic antagonist |
| promethazine | [no description available] | medium | 1 | 0 | phenothiazines; tertiary amine | anti-allergic agent; anticoronaviral agent; antiemetic; antipruritic drug; H1-receptor antagonist; local anaesthetic; sedative |
| proxymetacaine | [no description available] | medium | 2 | 0 | benzoate ester | |
| protriptyline | [no description available] | medium | 1 | 0 | carbotricyclic compound | antidepressant |
| pyrilamine | [no description available] | medium | 1 | 0 | aromatic ether; ethylenediamine derivative | H1-receptor antagonist |
| 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone | [no description available] | medium | 1 | 0 | methoxybenzenes | |
| rolipram | [no description available] | medium | 1 | 0 | pyrrolidin-2-ones | antidepressant; EC 3.1.4.* (phosphoric diester hydrolase) inhibitor |
| secobarbital | [no description available] | medium | 1 | 0 | barbiturates | anaesthesia adjuvant; GABA modulator; sedative |
| sotalol | [no description available] | medium | 1 | 0 | ethanolamines; secondary alcohol; secondary amino compound; sulfonamide | anti-arrhythmia drug; beta-adrenergic antagonist; environmental contaminant; xenobiotic |
| spiperone | [no description available] | medium | 1 | 0 | aromatic ketone; azaspiro compound; organofluorine compound; piperidines; tertiary amino compound | alpha-adrenergic antagonist; antipsychotic agent; dopaminergic antagonist; psychotropic drug; serotonergic antagonist |
| tetracaine | [no description available] | medium | 4 | 0 | benzoate ester; tertiary amino compound | local anaesthetic |
| thioridazine | [no description available] | medium | 1 | 0 | phenothiazines; piperidines | alpha-adrenergic antagonist; dopaminergic antagonist; EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; first generation antipsychotic; H1-receptor antagonist; serotonergic antagonist |
| trazodone | [no description available] | medium | 1 | 0 | monochlorobenzenes; N-alkylpiperazine; N-arylpiperazine; triazolopyridine | adrenergic antagonist; antidepressant; anxiolytic drug; H1-receptor antagonist; sedative; serotonin uptake inhibitor |
| trequinsin | [no description available] | medium | 1 | 0 | pyridopyrimidine | |
| trifluoperazine | [no description available] | medium | 1 | 0 | N-alkylpiperazine; N-methylpiperazine; organofluorine compound; phenothiazines | antiemetic; calmodulin antagonist; dopaminergic antagonist; EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor; EC 5.3.3.5 (cholestenol Delta-isomerase) inhibitor; phenothiazine antipsychotic drug |
| reserpine | [no description available] | medium | 1 | 0 | alkaloid ester; methyl ester; yohimban alkaloid | adrenergic uptake inhibitor; antihypertensive agent; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; environmental contaminant; first generation antipsychotic; plant metabolite; xenobiotic |
| phentolamine | [no description available] | medium | 1 | 0 | imidazoles; phenols; substituted aniline; tertiary amino compound | alpha-adrenergic antagonist; vasodilator agent |
| hexobendine | [no description available] | medium | 1 | 0 | trihydroxybenzoic acid | |
| dichloroisoproterenol | [no description available] | medium | 1 | 0 | ||
| tetraethylammonium chloride | [no description available] | medium | 1 | 0 | organic chloride salt; quaternary ammonium salt | potassium channel blocker |
| tetrabenazine | [no description available] | medium | 1 | 0 | benzoquinolizine; cyclic ketone; tertiary amino compound | |
| piperoxan | [no description available] | medium | 1 | 0 | ||
| nifenalol | [no description available] | medium | 1 | 0 | C-nitro compound | |
| brompheniramine | [no description available] | medium | 1 | 0 | organobromine compound; pyridines | anti-allergic agent; H1-receptor antagonist |
| propoxycaine | [no description available] | medium | 1 | 0 | benzoate ester | |
| dimethisoquin | [no description available] | medium | 1 | 0 | isoquinolines | |
| parethoxycaine | [no description available] | medium | 2 | 0 | benzoate ester | |
| yohimbine | [no description available] | medium | 1 | 0 | methyl 17-hydroxy-20xi-yohimban-16-carboxylate | alpha-adrenergic antagonist; dopamine receptor D2 antagonist; serotonergic antagonist |
| 2-chloroadenosine | [no description available] | medium | 1 | 0 | purine nucleoside | |
| prenylamine | [no description available] | medium | 1 | 0 | diarylmethane | |
| bicuculline | [no description available] | medium | 1 | 0 | benzylisoquinoline alkaloid; isoquinoline alkaloid; isoquinolines | agrochemical; central nervous system stimulant; GABA-gated chloride channel antagonist; GABAA receptor antagonist; neurotoxin |
| piperocaine | [no description available] | medium | 2 | 0 | benzoate ester | |
| diperodon | [no description available] | medium | 1 | 0 | carbamate ester | |
| cyclomethycaine | [no description available] | medium | 1 | 0 | benzoate ester | |
| carcainium chloride | [no description available] | medium | 1 | 0 | ||
| azacyclonol | [no description available] | medium | 1 | 0 | diarylmethane | |
| butoxamine | [no description available] | medium | 1 | 0 | ||
| dexpropranolol | [no description available] | medium | 1 | 0 | propranolol | |
| iprindole | [no description available] | medium | 1 | 0 | indoles | |
| carticaine | [no description available] | medium | 2 | 0 | thiophenecarboxylic acid | |
| timolol | [no description available] | medium | 1 | 0 | timolol | anti-arrhythmia drug; antiglaucoma drug; antihypertensive agent; beta-adrenergic antagonist |
| butaclamol | [no description available] | medium | 1 | 0 | organic heteropentacyclic compound | |
| etidocaine | [no description available] | medium | 2 | 0 | amino acid amide | local anaesthetic |
| diltiazem | [no description available] | medium | 1 | 0 | 5-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl acetate | antihypertensive agent; calcium channel blocker; vasodilator agent |
| Arbaclofen | [no description available] | medium | 1 | 0 | organonitrogen compound; organooxygen compound | |
| colforsin | [no description available] | medium | 1 | 0 | acetate ester; cyclic ketone; labdane diterpenoid; organic heterotricyclic compound; tertiary alpha-hydroxy ketone; triol | adenylate cyclase agonist; anti-HIV agent; antihypertensive agent; plant metabolite; platelet aggregation inhibitor; protein kinase A agonist |
| opromazine | [no description available] | medium | 1 | 0 | phenothiazines | |
| corynanthine | [no description available] | medium | 1 | 0 | yohimban alkaloid | |
| phenylisopropyladenosine | [no description available] | medium | 1 | 0 | aromatic amine; benzenes; hydrocarbyladenosine; purine nucleoside; secondary amino compound | adenosine A1 receptor agonist; neuroprotective agent |
| w 7 | [no description available] | medium | 1 | 0 | ||
| 2-n-butyl-3-(dimethylamino)-5,6-methylenedioxyindene | [no description available] | medium | 1 | 0 | ||
| rac 109 | [no description available] | medium | 1 | 0 | ||
| atropine | [no description available] | medium | 1 | 0 | ||
| strychnine | [no description available] | medium | 1 | 0 | monoterpenoid indole alkaloid; organic heteroheptacyclic compound | avicide; cholinergic antagonist; glycine receptor antagonist; neurotransmitter agent; rodenticide |
| quinidine | [no description available] | medium | 1 | 0 | cinchona alkaloid | alpha-adrenergic antagonist; anti-arrhythmia drug; antimalarial; drug allergen; EC 1.14.13.181 (13-deoxydaunorubicin hydroxylase) inhibitor; EC 3.6.3.44 (xenobiotic-transporting ATPase) inhibitor; muscarinic antagonist; P450 inhibitor; potassium channel blocker; sodium channel blocker |
| cocaine | [no description available] | medium | 3 | 0 | benzoate ester; methyl ester; tertiary amino compound; tropane alkaloid | adrenergic uptake inhibitor; central nervous system stimulant; dopamine uptake inhibitor; environmental contaminant; local anaesthetic; mouse metabolite; plant metabolite; serotonin uptake inhibitor; sodium channel blocker; sympathomimetic agent; vasoconstrictor agent; xenobiotic |
| diethylstilbestrol | [no description available] | medium | 1 | 0 | olefinic compound; polyphenol | antifungal agent; antineoplastic agent; autophagy inducer; calcium channel blocker; carcinogenic agent; EC 1.1.1.146 (11beta-hydroxysteroid dehydrogenase) inhibitor; EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor; endocrine disruptor; xenoestrogen |
| rauwolscine | [no description available] | medium | 1 | 0 | methyl 17-hydroxy-20xi-yohimban-16-carboxylate | |
| chlorprothixene | [no description available] | medium | 1 | 0 | chlorprothixene | |
| flunarizine | [no description available] | medium | 1 | 0 | diarylmethane | |
| thiothixene | [no description available] | medium | 1 | 0 | N-methylpiperazine | anticoronaviral agent |
| cinnarizine | [no description available] | medium | 1 | 0 | diarylmethane; N-alkylpiperazine; olefinic compound | anti-allergic agent; antiemetic; calcium channel blocker; geroprotector; H1-receptor antagonist; histamine antagonist; muscarinic antagonist |
| quinine | [no description available] | medium | 1 | 0 | cinchona alkaloid | antimalarial; muscle relaxant; non-narcotic analgesic |
| codeine | [no description available] | medium | 1 | 0 | morphinane alkaloid; organic heteropentacyclic compound | antitussive; drug allergen; environmental contaminant; opioid analgesic; opioid receptor agonist; prodrug; xenobiotic |
| morphine | [no description available] | medium | 1 | 0 | morphinane alkaloid; organic heteropentacyclic compound; tertiary amino compound | anaesthetic; drug allergen; environmental contaminant; geroprotector; mu-opioid receptor agonist; opioid analgesic; plant metabolite; vasodilator agent; xenobiotic |
| levorphanol | [no description available] | medium | 1 | 0 | morphinane alkaloid | |
| dextrorphan | [no description available] | medium | 1 | 0 | morphinane alkaloid | |
| zimeldine | [no description available] | medium | 1 | 0 | styrenes | |
| 1-methyl-d-lysergic acid butanolamide | [no description available] | medium | 1 | 0 | ergot alkaloid; monocarboxylic acid amide | serotonergic antagonist; sympatholytic agent; vasoconstrictor agent |
| scopolamine hydrobromide | [no description available] | medium | 1 | 0 | ||
| propoxycaine hydrochloride | [no description available] | medium | 1 | 0 | ||
| cardiovascular agents | [no description available] | medium | 1 | 0 | ||
| citric acid, anhydrous | [no description available] | medium | 1 | 0 | tricarboxylic acid | antimicrobial agent; chelator; food acidity regulator; fundamental metabolite |
| carbachol | [no description available] | medium | 1 | 0 | ammonium salt; carbamate ester | cardiotonic drug; miotic; muscarinic agonist; nicotinic acetylcholine receptor agonist; non-narcotic analgesic |
| histamine | [no description available] | medium | 1 | 0 | aralkylamino compound; imidazoles | human metabolite; mouse metabolite; neurotransmitter |
| isoproterenol | [no description available] | medium | 1 | 0 | catechols; secondary alcohol; secondary amino compound | beta-adrenergic agonist; bronchodilator agent; cardiotonic drug; sympathomimetic agent |
| digallic acid | [no description available] | low | 0 | 0 | benzoate ester; gallate ester | |
| mdl 72222 | [no description available] | low | 0 | 0 | benzoate ester | |
| benfluorex | [no description available] | low | 0 | 0 | benzoate ester | |
| benzyl benzoate | [no description available] | low | 0 | 0 | benzoate ester; benzyl ester | acaricide; plant metabolite; scabicide |
| camostat | [no description available] | low | 0 | 0 | benzoate ester; carboxylic ester; diester; guanidines; tertiary carboxamide | anti-inflammatory agent; anticoronaviral agent; antifibrinolytic drug; antihypertensive agent; antineoplastic agent; antiviral agent; serine protease inhibitor |
| ethyl piperidinoacetylaminobenzoate | [no description available] | low | 0 | 0 | benzoate ester; piperidines | |
| gabexate | [no description available] | low | 0 | 0 | benzoate ester | |
| methyl salicylate | [no description available] | low | 0 | 0 | benzoate ester; methyl ester; salicylates | flavouring agent; insect attractant; metabolite |
| Phenyliodoundecynoate | [no description available] | low | 0 | 0 | benzoate ester; phenols | |
| salicylsalicylic acid | [no description available] | low | 0 | 0 | benzoate ester; benzoic acids; phenols; salicylates | antineoplastic agent; antirheumatic drug; EC 3.5.2.6 (beta-lactamase) inhibitor; hypoglycemic agent; non-narcotic analgesic; non-steroidal anti-inflammatory drug; prodrug |
| butyl phthalyl butyl glycolate | [no description available] | low | 0 | 0 | benzoate ester | |
| methyl n-methylanthranilate | [no description available] | low | 0 | 0 | benzoate ester; methyl ester; secondary amino compound; substituted aniline | animal metabolite; fungal metabolite; plant metabolite |
| isoamyl salicylate | [no description available] | low | 0 | 0 | benzoate ester; phenols | |
| Ethyl 2-aminobenzoate | [no description available] | low | 0 | 0 | benzoate ester | |
| acetyleugenol | [no description available] | low | 0 | 0 | benzoate ester; phenols | |
| methyl benzoate | [no description available] | low | 0 | 0 | benzoate ester; methyl ester | insect attractant; metabolite |
| ethyl benzoate | [no description available] | low | 0 | 0 | benzoate ester; ethyl ester | flavouring agent; fragrance; volatile oil component |
| diphenylcarboxylate | [no description available] | low | 0 | 0 | benzoate ester | |
| propylparaben | [no description available] | low | 0 | 0 | benzoate ester; paraben; phenols | antifungal agent; antimicrobial agent |
| dimethocaine | [no description available] | low | 0 | 0 | benzoate ester | |
| benzylparaben | [no description available] | low | 0 | 0 | benzoate ester; benzyl ester | |
| benzonatate | [no description available] | low | 0 | 0 | benzoate ester; secondary amino compound; substituted aniline | anaesthetic; antitussive |
| oxyphenisatin acetate | [no description available] | low | 0 | 0 | benzoate ester; phenols | |
| phenyl salicylate | [no description available] | low | 0 | 0 | benzoate ester; phenols; salicylates | ultraviolet filter |
| homosalate | [no description available] | low | 0 | 0 | benzoate ester; phenols | |
| benzyl salicylate | [no description available] | low | 0 | 0 | benzoate ester; phenols | |
| 2-ethylhexyl salicylate | [no description available] | low | 0 | 0 | benzoate ester; phenols | |
| methyl 4-anisate | [no description available] | low | 0 | 0 | benzoate ester; monomethoxybenzene | |
| deserpidine | [no description available] | low | 0 | 0 | alkaloid ester; benzoate ester; methyl ester; organic heteropentacyclic compound; yohimban alkaloid | |
| chloroprocaine | [no description available] | low | 0 | 0 | benzoate ester; monochlorobenzenes | central nervous system depressant; local anaesthetic; peripheral nervous system drug |
| 2-Phenylethyl 2-aminobenzoate | [no description available] | low | 0 | 0 | benzoate ester | |
| methyl anthranilate | [no description available] | low | 0 | 0 | benzoate ester | flavouring agent; metabolite |
| resorcinol monobenzoate | [no description available] | low | 0 | 0 | benzoate ester | allergen |
| tetrracaine hydrochloride | [no description available] | low | 0 | 0 | benzoate ester | |
| p-cresyl acetate | [no description available] | low | 0 | 0 | benzoate ester; phenols | |
| amylocaine | [no description available] | low | 0 | 0 | benzoate ester | |
| benzoylcholine | [no description available] | low | 0 | 0 | benzoate ester | |
| propyl benzoate | [no description available] | low | 0 | 0 | benzoate ester | antimicrobial food preservative; flavouring agent; plant metabolite |
| tri-(2-ethylhexyl)trimellitate | [no description available] | low | 0 | 0 | benzoate ester | |
| cue-lure | [no description available] | low | 0 | 0 | benzoate ester; phenols | |
| metabutoxycaine | [no description available] | low | 0 | 0 | benzoate ester | |
| methyl vanillate | [no description available] | low | 0 | 0 | aromatic ether; benzoate ester; phenols | antioxidant; plant metabolite |
| hexyl salicylate | [no description available] | low | 0 | 0 | benzoate ester | |
| 2-Propenyl 2-aminobenzoate | [no description available] | low | 0 | 0 | benzoate ester | |
| ethyl 4-dimethylaminobenzoate | [no description available] | low | 0 | 0 | benzoate ester; ethyl ester; tertiary amino compound | |
| padimate-o | [no description available] | low | 0 | 0 | benzoate ester | |
| etofenamate | [no description available] | low | 0 | 0 | benzoate ester | |
| 2-aminosulfonyl-benzoic acid methyl ester | [no description available] | low | 0 | 0 | benzoate ester; methyl ester; sulfonamide | marine xenobiotic metabolite |
| bopindolol | [no description available] | low | 0 | 0 | aromatic ether; benzoate ester; methylindole; secondary amino compound | |
| sulfometuron methyl | [no description available] | low | 0 | 0 | benzoate ester; N-sulfonylurea; pyrimidines | EC 2.2.1.6 (acetolactate synthase) inhibitor; herbicide |
| metsulfuron methyl | [no description available] | low | 0 | 0 | 1,3,5-triazines; benzoate ester; N-sulfonylurea | environmental contaminant; herbicide; xenobiotic |
| baccatin iii | [no description available] | low | 0 | 0 | acetate ester; benzoate ester; tetracyclic diterpenoid | plant metabolite |
| cresatin | [no description available] | low | 0 | 0 | benzoate ester; phenols | |
| ibopamine | [no description available] | low | 0 | 0 | benzoate ester; phenols | |
| methyl syringate | [no description available] | low | 0 | 0 | benzoate ester; dimethoxybenzene; phenols | plant metabolite |
| methyl gentisate | [no description available] | low | 0 | 0 | benzoate ester; phenols | |
| benzoylmetronidazole | [no description available] | low | 0 | 0 | benzoate ester | antibacterial drug; antimicrobial agent; antiparasitic agent; antitrichomonal drug; prodrug |
| isoamyl 4-n,n-dimethylaminobenzoate | [no description available] | low | 0 | 0 | benzoate ester | |
| methyl 2-(((((4-ethoxy-6-(methylamino)-1,3,5-triazin-2-yl)amino)carbonyl)amino)sulfonyl)benzoate | [no description available] | low | 0 | 0 | aromatic ether; benzoate ester; diamino-1,3,5-triazine; methyl ester; N-sulfonylurea | EC 2.2.1.6 (acetolactate synthase) inhibitor; herbicide |
| triflusulfuron-methyl | [no description available] | low | 0 | 0 | 1,3,5-triazines; aromatic ether; benzoate ester; methyl ester; N-sulfonylurea; organofluorine compound; tertiary amino compound | agrochemical; EC 2.2.1.6 (acetolactate synthase) inhibitor; proherbicide |
| lecanoric acid | [no description available] | low | 0 | 0 | benzoate ester | |
| Meprylcaine hydrochloride | [no description available] | low | 0 | 0 | benzoate ester | |
| 4-acetamidophenyl-2-thiophenecarboxylate | [no description available] | low | 0 | 0 | benzoate ester; phenols | |
| 8-hydroxynorcocaine | [no description available] | low | 0 | 0 | benzoate ester | |
| succinobucol | [no description available] | low | 0 | 0 | benzoate ester; phenols | |
| estradiol 3-benzoate | [no description available] | low | 0 | 0 | 17beta-hydroxy steroid; benzoate ester | estrogen receptor agonist; xenoestrogen |
| cochlearine | [no description available] | low | 0 | 0 | benzoate ester | |
| 3-(2-Methylpropanoyloxy)-8-(2-methylbutanoyloxy)-9,10-epoxy-p-mentha-1,3,5-triene | [no description available] | low | 0 | 0 | benzoate ester; phenols | |
| agnuside | [no description available] | low | 0 | 0 | benzoate ester; beta-D-glucoside; cyclopentapyran; iridoid monoterpenoid; monosaccharide derivative; phenols; terpene glycoside | anti-inflammatory agent; cyclooxygenase 2 inhibitor; plant metabolite; pro-angiogenic agent |
| benzoylecgonine | [no description available] | low | 0 | 0 | benzoate ester; tropane alkaloid | epitope; human xenobiotic metabolite; marine xenobiotic metabolite; plant metabolite |
| 4-[2-(4-methoxycarbonylphenyl)iminohydrazinyl]benzoic acid methyl ester | [no description available] | low | 0 | 0 | benzoate ester | |
| cocaethylene | [no description available] | low | 0 | 0 | benzoate ester | |
| norcocaine | [no description available] | low | 0 | 0 | benzoate ester | |
| 2,4-dichlorobenzoic acid 1,2,4-triazol-1-ylmethyl ester | [no description available] | low | 0 | 0 | benzoate ester | |
| 4-[[[[8-[(1-tert-butyl-5-tetrazolyl)methyl]-8-azabicyclo[3.2.1]octan-3-yl]amino]-oxomethyl]amino]benzoic acid ethyl ester | [no description available] | low | 0 | 0 | benzoate ester | |
| benzoic acid [5-amino-1-(4-methoxyphenyl)sulfonyl-3-pyrazolyl] ester | [no description available] | low | 0 | 0 | benzoate ester | |
| Methyl 2-[(methylsulfonyl)amino]benzoate | [no description available] | low | 0 | 0 | benzoate ester | |
| 4-[[[2-(4-fluorophenyl)ethylamino]-sulfanylidenemethyl]amino]benzoic acid ethyl ester | [no description available] | low | 0 | 0 | benzoate ester | |
| acetic acid [4-[oxo-(2-phenylethylamino)methyl]phenyl] ester | [no description available] | low | 0 | 0 | benzoate ester; phenols | |
| 4-[[[2-(3-methylphenyl)ethylamino]-sulfanylidenemethyl]amino]benzoic acid methyl ester | [no description available] | low | 0 | 0 | benzoate ester | |
| acetic acid [2-(4-acetamido-6-phenyl-1,3,5-triazin-2-yl)phenyl] ester | [no description available] | low | 0 | 0 | benzoate ester; phenols | |
| benzoic acid (2-oxo-2-thiophen-2-ylethyl) ester | [no description available] | low | 0 | 0 | benzoate ester | |
| 4-[5-[oxo-(3-pyridinylamino)methyl]-2-furanyl]benzoic acid ethyl ester | [no description available] | low | 0 | 0 | benzoate ester | |
| 4-[[(cyclohexylamino)-oxomethyl]amino]benzoic acid methyl ester | [no description available] | low | 0 | 0 | benzoate ester | |
| 4-[[(4-hydroxy-1-piperidinyl)-sulfanylidenemethyl]amino]benzoic acid ethyl ester | [no description available] | low | 0 | 0 | benzoate ester | |
| 2-[[(1,3-benzodioxol-5-ylamino)-oxomethyl]amino]benzoic acid methyl ester | [no description available] | low | 0 | 0 | benzoate ester | |
| 2-[[[(5-chloro-2-pyridinyl)amino]-oxomethyl]amino]benzoic acid methyl ester | [no description available] | low | 0 | 0 | benzoate ester | |
| 4-[[(4-methoxyanilino)-oxomethyl]amino]benzoic acid methyl ester | [no description available] | low | 0 | 0 | benzoate ester | |
| 4-[[[(2-methoxyphenyl)methylamino]-oxomethyl]amino]benzoic acid ethyl ester | [no description available] | low | 0 | 0 | benzoate ester | |
| 4-[[1-azepanyl(oxo)methyl]amino]benzoic acid ethyl ester | [no description available] | low | 0 | 0 | benzoate ester | |
| 2-[[(4-methyl-1-pyrazolyl)-oxomethyl]amino]benzoic acid methyl ester | [no description available] | low | 0 | 0 | benzoate ester | |
| 4-[5-(2-phenylethyl)-2-sulfanylidene-1,3,5-triazinan-1-yl]benzoic acid ethyl ester | [no description available] | low | 0 | 0 | benzoate ester | |
| 4-(4-methoxycarbonylphenyl)-1,2,6-trimethyl-4H-pyridine-3,5-dicarboxylic acid dimethyl ester | [no description available] | low | 0 | 0 | benzoate ester | |
| 3-[[oxo-[3-(5-phenyl-1,3,4-oxadiazol-2-yl)phenyl]methoxy]methyl]benzoic acid ethyl ester | [no description available] | low | 0 | 0 | benzoate ester | |
| 4-[[diethylamino(oxo)methyl]amino]benzoic acid ethyl ester | [no description available] | low | 0 | 0 | benzoate ester | |
| 4-(5-formyl-2-furanyl)benzoic acid propyl ester | [no description available] | low | 0 | 0 | benzoate ester | |
| 4-[[(3,4-dimethoxyanilino)-oxomethyl]amino]benzoic acid butyl ester | [no description available] | low | 0 | 0 | benzoate ester | |
| 4-(dimethylamino)benzoic acid (3,5-dimethyl-4-isoxazolyl)methyl ester | [no description available] | low | 0 | 0 | benzoate ester | |
| 2-[4-(difluoromethylthio)anilino]benzoic acid [2-(cyclopropylamino)-2-oxoethyl] ester | [no description available] | low | 0 | 0 | benzoate ester | |
| 2-hydroxybenzoic acid [2-[[(1-methyl-2-pyrrolyl)-oxomethyl]amino]-2-oxoethyl] ester | [no description available] | low | 0 | 0 | benzoate ester; phenols | |
| 4-[(2-methoxyphenyl)-methylsulfamoyl]benzoic acid [2-[(5-methyl-3-isoxazolyl)amino]-2-oxoethyl] ester | [no description available] | low | 0 | 0 | benzoate ester | |
| 3-[(2-methoxyphenyl)-prop-2-enylsulfamoyl]benzoic acid [2-(1H-indol-3-yl)-2-oxoethyl] ester | [no description available] | low | 0 | 0 | benzoate ester | |
| 4-chloro-3-(1-piperidinylsulfonyl)benzoic acid [2-(4-amino-1,3-dimethyl-2,6-dioxo-5-pyrimidinyl)-2-oxoethyl] ester | [no description available] | low | 0 | 0 | benzoate ester | |
| 2-[2-nitro-4-(trifluoromethyl)phenyl]sulfinylacetic acid (4-chlorophenyl) ester | [no description available] | low | 0 | 0 | benzoate ester; phenols | |
| 4-[[[(2-methoxy-1-oxoethyl)hydrazo]-sulfanylidenemethyl]amino]benzoic acid ethyl ester | [no description available] | low | 0 | 0 | benzoate ester | |
| acetic acid [4-[(1-oxo-2-phenylethyl)amino]phenyl] ester | [no description available] | low | 0 | 0 | benzoate ester; phenols | |
| 3-(dimethylamino)propyl benzoate | [no description available] | low | 0 | 0 | benzoate ester | |
| 2,4-difluorobenzoic acid [2-(cyclopropylamino)-2-oxoethyl] ester | [no description available] | low | 0 | 0 | benzoate ester | |
| benzoic acid [2-(2-furanylmethylamino)-2-oxoethyl] ester | [no description available] | low | 0 | 0 | benzoate ester | |
| 4-(diethylsulfamoyl)benzoic acid [2-[4-(6-methyl-1,3-benzothiazol-2-yl)anilino]-2-oxoethyl] ester | [no description available] | low | 0 | 0 | benzoate ester | |
| 4-methylbenzoic acid [2-(1H-indol-3-yl)-2-oxoethyl] ester | [no description available] | low | 0 | 0 | benzoate ester | |
| 2-ethoxy-3-pyridinecarboxylic acid (4-methoxycarbonylphenyl)methyl ester | [no description available] | low | 0 | 0 | benzoate ester | |
| 4-(dimethylamino)benzoic acid [2-(cycloheptylamino)-2-oxoethyl] ester | [no description available] | low | 0 | 0 | benzoate ester | |
| 2-(thiophen-2-ylsulfonylamino)benzoic acid [2-(cyclohexylamino)-2-oxoethyl] ester | [no description available] | low | 0 | 0 | benzoate ester | |
| 2-(2-furanylmethylamino)benzoic acid [2-oxo-2-(3-oxo-2,4-dihydroquinoxalin-1-yl)ethyl] ester | [no description available] | low | 0 | 0 | benzoate ester | |
| 2-hydroxy-4-methylbenzoic acid [2-(2-chloroanilino)-2-oxoethyl] ester | [no description available] | low | 0 | 0 | benzoate ester; phenols | |
| 4-(dimethylsulfamoyl)benzoic acid [2-(2-furanylmethylamino)-2-oxoethyl] ester | [no description available] | low | 0 | 0 | benzoate ester | |
| 2-[[2-[(2-hydroxyphenyl)-oxomethoxy]-1-oxoethyl]amino]-5,6,7,8-tetrahydro-4H-cyclohepta[b]thiophene-3-carboxylic acid methyl ester | [no description available] | low | 0 | 0 | benzoate ester; phenols | |
| 4-chloro-3-(1-pyrrolidinylsulfonyl)benzoic acid [2-(butylamino)-2-oxoethyl] ester | [no description available] | low | 0 | 0 | benzoate ester | |
| 3-hydroxybenzoic acid [2-(1H-indol-3-yl)-2-oxoethyl] ester | [no description available] | low | 0 | 0 | benzoate ester; phenols | |
| 3,4-diethoxybenzoic acid [2-[(5-methyl-3-isoxazolyl)amino]-2-oxoethyl] ester | [no description available] | low | 0 | 0 | benzoate ester | |
| 3-[(3,4-difluorophenyl)sulfonylamino]benzoic acid [2-[[(2-methylpropylamino)-oxomethyl]amino]-2-oxoethyl] ester | [no description available] | low | 0 | 0 | benzoate ester | |
| 2-(butylamino)benzoic acid [2-oxo-2-(4-sulfamoylanilino)ethyl] ester | [no description available] | low | 0 | 0 | benzoate ester | |
| 3-(diethylsulfamoyl)benzoic acid [2-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-oxoethyl] ester | [no description available] | low | 0 | 0 | benzoate ester | |
| 4-(diethylsulfamoyl)benzoic acid 1,3-benzodioxol-5-yl ester | [no description available] | low | 0 | 0 | benzoate ester | |
| 3-(methanesulfonamido)benzoic acid methyl ester | [no description available] | low | 0 | 0 | benzoate ester | |
| ethyl 3-amino-4-(methylamino)benzoate | [no description available] | low | 0 | 0 | benzoate ester | |
| 2-[[3-(methylthio)-1,2,4-thiadiazol-5-yl]thio]acetic acid (4-acetamidophenyl) ester | [no description available] | low | 0 | 0 | benzoate ester; phenols | |
| 3-amino-4-chlorobenzoic acid [2-oxo-2-(1-pyrrolidinyl)ethyl] ester | [no description available] | low | 0 | 0 | benzoate ester | |
| 2-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonylamino)benzoic acid thiophen-2-ylmethyl ester | [no description available] | low | 0 | 0 | benzoate ester | |
| 2-amino-4-chlorobenzoic acid [2-oxo-2-(3,3,5-trimethyl-7-azabicyclo[3.2.1]octan-7-yl)ethyl] ester | [no description available] | low | 0 | 0 | benzoate ester | |
| 2,6-difluorobenzoic acid 2,3-dihydro-1,4-benzodioxin-3-ylmethyl ester | [no description available] | low | 0 | 0 | benzoate ester | |
| 3-[(4-methylphenyl)sulfamoyl]benzoic acid [2-(2-furanylmethylamino)-2-oxoethyl] ester | [no description available] | low | 0 | 0 | benzoate ester | |
| bentiamine | [no description available] | low | 0 | 0 | benzoate ester | |
| 3-[5-[bis(3-methyl-5-oxo-1,2-dihydropyrazol-4-yl)methyl]-2-furanyl]benzoic acid methyl ester | [no description available] | low | 0 | 0 | benzoate ester | |
| 4-[2-(cyclohexylamino)-2-oxo-1-[(1-oxo-2-thiophen-2-ylethyl)-(phenylmethyl)amino]ethyl]benzoic acid methyl ester | [no description available] | low | 0 | 0 | benzoate ester | |
| 4-[[(2,3-dihydro-1H-inden-1-ylamino)-sulfanylidenemethyl]amino]benzoic acid methyl ester | [no description available] | low | 0 | 0 | benzoate ester | |
| 3,4-dimethylbenzoic acid (6-methyl-3-pyridinyl) ester | [no description available] | low | 0 | 0 | benzoate ester | |
| benzoic acid [4-(6-amino-5-cyano-3-methyl-2,4-dihydropyrano[2,3-c]pyrazol-4-yl)-2-methoxyphenyl] ester | [no description available] | low | 0 | 0 | benzoate ester; pyranopyrazole | |
| 4-chlorobenzoic acid (5-methyl-2-pyridin-4-yl-4-thiazolyl) ester | [no description available] | low | 0 | 0 | benzoate ester | |
| 4-[3-methyl-5-(4-methylphenyl)-6-oxo-2,4-dihydropyrrolo[3,4-c]pyrazol-4-yl]benzoic acid methyl ester | [no description available] | low | 0 | 0 | benzoate ester | |
| 5-(diethylsulfamoyl)-2-hydroxybenzoic acid [2-oxo-2-[4-(trifluoromethoxy)anilino]ethyl] ester | [no description available] | low | 0 | 0 | benzoate ester; phenols | |
| 4-[[[2-(4-methoxyphenyl)-3-thiazolidinyl]-sulfanylidenemethyl]amino]benzoic acid ethyl ester | [no description available] | low | 0 | 0 | benzoate ester | |
| 4-(carbamoylamino)benzoic acid [2-(3-chloro-4-methylanilino)-2-oxo-1-phenylethyl] ester | [no description available] | low | 0 | 0 | benzoate ester | |
| 2-hydroxybenzoic acid [2-(2-ethoxyanilino)-2-oxo-1-phenylethyl] ester | [no description available] | low | 0 | 0 | benzoate ester; phenols | |
| 2-(2-furanylmethylamino)benzoic acid [2-[(3-cyano-6-methyl-4,5,6,7-tetrahydro-1-benzothiophen-2-yl)amino]-2-oxoethyl] ester | [no description available] | low | 0 | 0 | benzoate ester | |
| acetic acid [2-[2-acetyl-3-(4-methoxyphenyl)-3,4-dihydropyrazol-5-yl]phenyl] ester | [no description available] | low | 0 | 0 | benzoate ester; phenols | |
| 3-pyridinecarboxylic acid [4-[heptoxy(oxo)methyl]phenyl] ester | [no description available] | low | 0 | 0 | benzoate ester | |
| 2-hydroxy-5-[(4-methoxyphenyl)sulfamoyl]benzoic acid [2-[1-(3-bicyclo[2.2.1]heptanyl)ethylamino]-2-oxoethyl] ester | [no description available] | low | 0 | 0 | benzoate ester; phenols | |
| 3,5-dimethyl-4-oxo-6-thieno[2,3-d]pyrimidinecarboxylic acid (4-methylphenyl) ester | [no description available] | low | 0 | 0 | benzoate ester; phenols | |
| 4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonylamino)benzoic acid [2-(cyclopropylamino)-2-oxoethyl] ester | [no description available] | low | 0 | 0 | benzoate ester | |
| 2-[4-(difluoromethylthio)anilino]benzoic acid [2-(dimethylamino)-2-oxoethyl] ester | [no description available] | low | 0 | 0 | benzoate ester | |
| 4-ethylbenzoic acid [2-(2-ethoxyanilino)-2-oxo-1-phenylethyl] ester | [no description available] | low | 0 | 0 | benzoate ester | |
| 4-[[[[2-(3-pyridinyl)-1-piperidinyl]amino]-sulfanylidenemethyl]amino]benzoic acid methyl ester | [no description available] | low | 0 | 0 | benzoate ester | |
| cinnamyl anthranilate | [no description available] | low | 0 | 0 | benzoate ester | |
| gabexate methanesulfonate | [no description available] | low | 0 | 0 | benzoate ester; guanidines; methanesulfonate salt | |
| yunaconitine | [no description available] | low | 0 | 0 | acetate ester; aromatic ether; benzoate ester; bridged compound; diterpene alkaloid; organic heteropolycyclic compound; polyether; secondary alcohol; tertiary alcohol; tertiary amino compound | antifeedant; human urinary metabolite; phytotoxin; plant metabolite; xenobiotic |
| paeonilide | [no description available] | low | 0 | 0 | benzoate ester | metabolite |
| 10-isobutyryloxy-8,9-epoxythymol isobutyrate | [no description available] | low | 0 | 0 | benzoate ester; phenols | |
| butafenacil | [no description available] | low | 0 | 0 | benzoate ester; diester; monochlorobenzenes; olefinic compound; organofluorine compound | EC 1.3.3.4 (protoporphyrinogen oxidase) inhibitor; herbicide |
| 4-[3-(2-furanyl)-4-(3-nitrophenyl)-6-oxo-2,4-dihydropyrrolo[3,4-c]pyrazol-5-yl]benzoic acid ethyl ester | [no description available] | low | 0 | 0 | benzoate ester | |
| 2-[[(4-methyl-1-piperidinyl)-sulfanylidenemethyl]amino]benzoic acid ethyl ester | [no description available] | low | 0 | 0 | benzoate ester | |
| 4-methylbenzoic acid [6-[[[5-[[cyclopropyl(oxo)methyl]amino]-1,3,4-thiadiazol-2-yl]thio]methyl]-4-oxo-3-pyranyl] ester | [no description available] | low | 0 | 0 | benzoate ester | |
| 4-[[4-cyclohexyl-3-(2-hydroxyethyl)-1-piperazinyl]methyl]benzoic acid methyl ester | [no description available] | low | 0 | 0 | benzoate ester | |
| 4-[[[2-(1-azepanyl)ethyl-(2-furanylmethyl)amino]-sulfanylidenemethyl]amino]benzoic acid ethyl ester | [no description available] | low | 0 | 0 | benzoate ester | |
| 2-[[[(1-ethyl-3,5-dimethyl-4-pyrazolyl)methylamino]-oxomethyl]amino]benzoic acid methyl ester | [no description available] | low | 0 | 0 | benzoate ester | |
| avilamycin a | [no description available] | low | 0 | 0 | benzoate ester; cyclic acetal; dichlorobenzene; oligosaccharide derivative; ortho ester; oxaspiro compound; phenols; tertiary alpha-hydroxy ketone | antimicrobial agent; bacterial metabolite |
| benzoylaconine | [no description available] | low | 0 | 0 | benzoate ester; bridged compound; diterpene alkaloid; organic heteropolycyclic compound; polyether; secondary alcohol; tertiary alcohol; tertiary amino compound; tetrol | phytotoxin; plant metabolite |
| deoxyaconitine | [no description available] | low | 0 | 0 | acetate ester; benzoate ester; bridged compound; diol; diterpene alkaloid; organic heteropolycyclic compound; polyether; secondary alcohol; tertiary amino compound | plant metabolite |
| benzoylmesaconine | [no description available] | low | 0 | 0 | benzoate ester; bridged compound; diterpene alkaloid; organic heteropolycyclic compound; polyether; secondary alcohol; tertiary alcohol; tertiary amino compound; tetrol | analgesic; antiinfective agent; plant metabolite |
| albiflorin | [no description available] | low | 0 | 0 | benzoate ester; beta-D-glucoside; bridged compound; gamma-lactone; monoterpene glycoside; secondary alcohol | neuroprotective agent; plant metabolite |
| brartemicin | [no description available] | low | 0 | 0 | benzoate ester; glycosyl glycoside derivative; resorcinols | antimicrobial agent; metabolite |
| armillaridin | [no description available] | low | 0 | 0 | benzoate ester; sesquiterpenoid | |
| brasilicardin a | [no description available] | low | 0 | 0 | benzoate ester; carbotricyclic compound; diterpenoid; N-acetyl-D-glucosaminide; non-proteinogenic alpha-amino acid; phenols | antimicrobial agent; antineoplastic agent; bacterial metabolite; immunosuppressive agent |
| paeoniflorigenone | [no description available] | low | 0 | 0 | alicyclic ketone; benzoate ester; bridged compound; cyclic acetal; lactol; monoterpenoid | neuromuscular agent; plant metabolite |
| 4-[[(4-oxo-1,5,6,7-tetrahydrocyclopenta[d]pyrimidin-2-yl)thio]methyl]benzoic acid methyl ester | [no description available] | low | 0 | 0 | benzoate ester |
| Condition | Indicated | Relationship Strength | Studies | Trials |
|---|---|---|---|---|
| Anemia, Fanconi | 0 | low | 1 | 0 |
| Anesthesia | 0 | low | 11 | 0 |
| Asthma | 0 | low | 1 | 0 |
| Asthma, Bronchial | 0 | low | 1 | 0 |
| Bronchial Asthma | 0 | low | 1 | 0 |
| Dermatoses | 0 | low | 1 | 0 |
| Dermatosis | 0 | low | 1 | 0 |
| Fanconi Anemia | 0 | low | 1 | 0 |
| Fanconi Hypoplastic Anemia | 0 | low | 1 | 0 |
| Fanconi Pancytopenia | 0 | low | 1 | 0 |
| Fanconi Panmyelopathy | 0 | low | 1 | 0 |
| Fanconi's Anemia | 0 | low | 1 | 0 |
| Itching | 0 | low | 1 | 0 |
| Pregnancy | 0 | low | 1 | 0 |
| Pruritis | 0 | low | 1 | 0 |
| Pruritus | 0 | low | 1 | 0 |
| Skin and Subcutaneous Tissue Disorders | 0 | low | 1 | 0 |
| Skin Diseases | 0 | low | 1 | 0 |